Dominion Energy Inc. (D) News
Filter D News Items
D News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
D News Highlights
- D's 30 day story count now stands at 10.
- Over the past 29 days, the trend for D's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- AQN, BASE and BMY are the most mentioned tickers in articles about D.
Latest D News From Around the Web
Below are the latest news stories about DOMINION ENERGY INC that investors may wish to consider to help them evaluate D as an investment opportunity.
Great week for Dominion Energy, Inc. (NYSE:D) institutional investors after losing 32% over the previous yearKey Insights Significantly high institutional ownership implies Dominion Energy's stock price is sensitive to their... |
Investors in Dominion Energy (NYSE:D) have unfortunately lost 35% over the last three yearsAs an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio... |
This Dividend Stock Is Changing, But It Still Won't Tell Investors HowDominion Energy is working on a strategic review, but other than some broad goals, it hasn't been forthcoming with information. |
AI May Be the Only Way to Make Money These DaysAI stocks are soaring. |
Dominion Energy encourages customers to prepare for hurricane seasonThe Atlantic hurricane season begins Thursday, June 1 and runs through Nov. 30. Dominion Energy encourages everyone to use this opportunity to make sure they are prepared for the next storm, whenever it may come. |
3 Top Stocks That Just Went on SaleShares of Walgreens Boots Alliance (NASDAQ: WBA), Bristol Myers Squibb (NYSE: BMY) and Dominion Energy (NYSE: D) all recently saw 52-week lows. Walgreens, like other pharmacy stocks, has seen earnings decline as foot traffic in stores has fallen. Pharmaceutical company Bristol Myers Squibb is facing increasing generic competition for its former top-selling oncology drug Relivimid, and has seen revenue decline. |
Based On Its ROE, Is Dominion Energy, Inc. (NYSE:D) A High Quality Stock?Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is... |
Dominion (D) Benefits From Investment in Renewable AssetsDominion Energy (D) is expected to benefit from the addition of clean assets in its portfolio and an increasing customer base. However, rising interest rates pose a concern. |
Dominion Energy (NYSE:D) Will Pay A Dividend Of $0.6675Dominion Energy, Inc.'s ( NYSE:D ) investors are due to receive a payment of $0.6675 per share on 20th of June. This... |
Does This Valuation Of Dominion Energy, Inc. (NYSE:D) Imply Investors Are Overpaying?Key Insights The projected fair value for Dominion Energy is US$43.07 based on Dividend Discount Model Dominion... |